Improved Metabolic Health: It supports better control of blood sugar levels and enhances overall metabolic health
Let us guide you through the best current options and prepare for future innovations in medical weight loss treatments
Sitagliptin, a DPP-4 inhibitor, improves myocardial response in coronary artery disease patients
Your weight loss depends on several factors, including: Lifestyle habits Dose Starting weight Overall health To experience consistent progress, its best to pair weight loss drugs (e.g., semaglutide, tirzepatide) with dietary changes, physical activity, and regular medical supervision
Biological ageing with HIV infection: evaluating the geroscience hypothesis
Alternative medication classes for diabetes (such as SGLT2 inhibitors) or weight management should be considered, recognizing that heart rate increases can occur with other GLP-1 receptor agonists as well